Net profit of Emmessar Biotech & Nutrition rose 500.00% to Rs 0.12 crore in the quarter ended December 2025 as against Rs 0.02 crore during the previous quarter ended December 2024. Sales declined 10.00% to Rs 0.09 crore in the quarter ended December 2025 as against Rs 0.10 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.090.10 -10 OPM %-366.67-280.00 - PBDT0.160.15 7 PBT0.130.13 0 NP0.120.02 500 Powered by Capital Market - Live News

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Net profit of Emmessar Biotech & Nutrition declined 60.71% to Rs 0.11 crore in the quarter ended September 2025 as against Rs 0.28 crore during the previous quarter ended September 2024. Sales declined 73.53% to Rs 0.09 crore in the quarter ended September 2025 as against Rs 0.34 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.090.34 -74 OPM %-411.11-23.53 - PBDT0.170.43 -60 PBT0.140.41 -66 NP0.110.28 -61 Powered by Capital Market - Live News

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Emmessar Biotech & Nutrition announced that the 33th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live News